Chandan Healthcare Limited Reports Strong Operational Update Amid Network Expansion and Sales Growth
Chandan Healthcare Limited, a leading integrated diagnostic service provider in North India, reported healthy operational performance for the quarter ended June 30, 2026. The company’s strong momentum is attributed to significant network expansion across its business verticals and increasing patient volumes.The operational update provides details on the growth of the diagnostic network, sales performance metrics, and key indicators across various business segments during the period.
Network Expansion Reaches New High
Chandan Healthcare Limited continued to strengthen its diagnostic presence by adding 140 new centers. This expansion brings the company’s total network strength to 327 centers as of June 30, 2026. The various categories of newly added and existing centers are detailed in the table below:| Centre Category | Added During Q1 FY 2026-27 | Total Network |
|---|---|---|
| Comprehensive Diagnostic Centres | 23 | |
| Diagnostic Centres | 17 | |
| Standalone Labs | 20 | |
| Franchise Centres | 264 | |
| Radiology Centres | 3 | |
| Total | 140 | 327 |
The expansion underscores the company's continuous focus on enhancing accessibility to quality diagnostic services across its operational markets.
Operational Sales and Financial Performance
The company recorded solid growth in operating sales during the quarter for both Chandan Healthcare Limited and its material subsidiary, Chandan Pharmacy Limited.| Particulars | Q1 FY 2025-26 (₹) | Q1 FY 2026-27 (₹) | YoY Growth |
|---|---|---|---|
| Chandan Healthcare Limited | 35,87,72,842.67 | 48,66,56,730.56 | 35.64% |
| Chandan Pharmacy Limited (Material Subsidiary) | 28,43,26,926.97 | 32,32,62,281.46 | 13.69% |
Business Growth and Patient Volume Trends
The company’s various business verticals demonstrated encouraging operational momentum during the quarter. In terms of overall business segment growth, performance indicators were as follows:| Business Segment | Growth |
|---|---|
| B2B (Business to Business) | 44% |
| B2G (Business to Government) | 22% |
| B2C (Referral & Online) | 20% |
Patient volume growth, tracked year-on-year across the major business segments, also registered healthy increases:
| Segment | Growth |
|---|---|
| General (Referral & Online) | 29% |
| Corporate | 24% |
| Government | 14% |
The operational highlights for the quarter include continued momentum across B2B, B2C, and Government business verticals. The company also expanded its franchise business, reinforcing its commitment to sustainable growth through continuous network expansion and operational excellence.
CHANDAN Stock Price Movement
Chandan Healthcare Limited shares slipped by 2.77% on Friday, settling at ₹249.65 as trading concluded for the session. The stock saw a distinct intraday range and recorded a volume of 36,800 shares during the period.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.